Johnson & Johnson (JNJ) Dividends Paid - Common Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Div. Paid (Common) Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
15.01% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
4.75% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
5.50% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
2.68% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
6.18% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
3.59% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
0.33% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
1.99% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
| Mar 29, 2026 |
4.75% |
| Dec 28, 2025 |
4.93% |
| Sep 28, 2025 |
4.92% |
| Jun 29, 2025 |
4.82% |
| Mar 30, 2025 |
4.18% |
| Dec 29, 2024 |
4.15% |
| Sep 29, 2024 |
3.97% |
| Jun 30, 2024 |
-3.46% |
| Mar 31, 2024 |
-2.48% |
| Dec 31, 2023 |
-16.74% |
| Apr 2, 2023 |
5.56% |
| Apr 3, 2022 |
4.81% |
| Oct 3, 2021 |
4.96% |
| Jul 4, 2021 |
4.96% |
| Apr 4, 2021 |
6.15% |
| Jan 3, 2021 |
6.32% |
| Sep 27, 2020 |
6.40% |
| Jun 28, 2020 |
5.43% |
| Mar 29, 2020 |
4.55% |
| Dec 29, 2019 |
3.69% |
| Sep 29, 2019 |
3.48% |
| Jun 30, 2019 |
4.43% |
| Mar 31, 2019 |
6.35% |
| Dec 30, 2018 |
6.87% |
| Sep 30, 2018 |
7.14% |
| Jul 1, 2018 |
6.76% |
| Apr 1, 2018 |
3.78% |
| Dec 31, 2017 |
-10.48% |
| Apr 2, 2017 |
4.93% |
| Apr 3, 2016 |
6.32% |
| Sep 27, 2015 |
5.54% |
| Jun 28, 2015 |
5.11% |
| Mar 29, 2015 |
4.23% |
| Dec 28, 2014 |
5.05% |
| Sep 28, 2014 |
5.64% |
| Jun 29, 2014 |
6.57% |
| Mar 30, 2014 |
9.44% |
| Dec 29, 2013 |
10.18% |
| Sep 29, 2013 |
10.64% |
| Jun 30, 2013 |
10.74% |
| Mar 31, 2013 |
9.01% |
| Dec 30, 2012 |
-7.80% |
| Apr 1, 2012 |
5.74% |
| Apr 3, 2011 |
9.63% |
| Oct 3, 2010 |
9.84% |
| Jul 4, 2010 |
10.30% |
| Apr 4, 2010 |
6.05% |